Company filings profile · CIK 0001411685

Vistagen Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Vistagen Therapeutics, Inc. (VTGN): 18 filings in the last 90 days vs 18 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 23, 2026. Source-linked, daily-refreshed.

Material 8-K events — Vistagen Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 22, 2026Other Events; Financial Statements and Exhibits
Sep 11, 2026Item 5.07; Financial Statements and Exhibits
Aug 14, 2026Results of Operations (earnings); Financial Statements and Exhibits
Aug 6, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Aug 5, 2026Delisting / Listing-Rule Failure
Jul 31, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jun 17, 2026Departure/Election of Directors or Officers
Jun 15, 2026Results of Operations (earnings); Financial Statements and Exhibits
Jun 9, 2026Other Events; Financial Statements and Exhibits
May 19, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
May 12, 2026Other Events; Financial Statements and Exhibits
May 8, 2026Other Events; Financial Statements and Exhibits
Apr 28, 2026Other Events; Financial Statements and Exhibits
Apr 13, 2026Departure/Election of Directors or Officers

Watch Vistagen Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jul 31, 20264
Jul 31, 20263
Jul 2, 20264
Jul 2, 20264
Jul 2, 20264
May 19, 20264
May 19, 20263
Apr 9, 20264
Apr 9, 20264
Apr 9, 20264
Apr 9, 20264
Apr 9, 20264
Jan 5, 20264
Dec 4, 20254
Dec 4, 20253

Recent filings

FiledFormDetail
Sep 22, 20268-K Other Events; Financial Statements and Exhibits
Sep 11, 20268-K Item 5.07; Financial Statements and Exhibits
Aug 14, 2026SCHEDULE 13G/A
Aug 14, 2026SCHEDULE 13G/A
Aug 14, 202610-Q 10-Q
Aug 14, 2026SCHEDULE 13G/A
Aug 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Aug 6, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Aug 5, 20268-K Delisting / Listing-Rule Failure
Jul 31, 2026DEFA14A DEFA14A
Jul 31, 2026DEF 14A DEF 14A
Jul 31, 20264
Jul 31, 20263
Jul 31, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Jul 2, 20264
Jul 2, 20264
Jul 2, 20264
Jun 30, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jun 17, 20268-K Departure/Election of Directors or Officers
Jun 15, 202610-K 10-K
Jun 15, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Jun 9, 20268-K Other Events; Financial Statements and Exhibits
May 19, 20264
May 19, 20263
May 19, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
May 15, 2026SCHEDULE 13G/A
May 12, 20268-K Other Events; Financial Statements and Exhibits
May 8, 20268-K Other Events; Financial Statements and Exhibits
Apr 28, 20268-K Other Events; Financial Statements and Exhibits
Apr 13, 20268-K Departure/Election of Directors or Officers
Apr 9, 20264 PRIMARY DOCUMENT
Apr 9, 20264 PRIMARY DOCUMENT
Apr 9, 20264 PRIMARY DOCUMENT
Apr 9, 20264 PRIMARY DOCUMENT
Apr 9, 20264 PRIMARY DOCUMENT
Apr 2, 20268-K Delisting / Listing-Rule Failure
Mar 18, 20268-K Departure/Election of Directors or Officers
Mar 16, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Mar 11, 20268-K Other Events
Feb 20, 20268-K Departure/Election of Directors or Officers